Savant Capital LLC grew its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 71.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 83,062 shares of the medical instruments supplier's stock after purchasing an additional 34,750 shares during the period. Savant Capital LLC's holdings in DENTSPLY SIRONA were worth $1,577,000 at the end of the most recent reporting period.
Several other large investors have also recently made changes to their positions in the company. FMR LLC lifted its position in DENTSPLY SIRONA by 5.1% during the third quarter. FMR LLC now owns 9,056,774 shares of the medical instruments supplier's stock valued at $245,076,000 after purchasing an additional 436,031 shares during the last quarter. Pacer Advisors Inc. lifted its holdings in shares of DENTSPLY SIRONA by 15,105.1% in the 4th quarter. Pacer Advisors Inc. now owns 4,503,591 shares of the medical instruments supplier's stock valued at $85,478,000 after acquiring an additional 4,473,972 shares during the last quarter. Charles Schwab Investment Management Inc. grew its position in DENTSPLY SIRONA by 50.4% in the third quarter. Charles Schwab Investment Management Inc. now owns 2,065,773 shares of the medical instruments supplier's stock worth $55,900,000 after acquiring an additional 692,100 shares in the last quarter. JPMorgan Chase & Co. grew its position in DENTSPLY SIRONA by 206.3% in the third quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier's stock worth $49,990,000 after acquiring an additional 1,244,326 shares in the last quarter. Finally, National Bank of Canada FI increased its stake in DENTSPLY SIRONA by 85.8% during the third quarter. National Bank of Canada FI now owns 1,628,200 shares of the medical instruments supplier's stock worth $44,059,000 after acquiring an additional 751,800 shares during the last quarter. 95.70% of the stock is owned by institutional investors.
DENTSPLY SIRONA Trading Down 2.4 %
Shares of DENTSPLY SIRONA stock traded down $0.45 on Monday, hitting $18.32. 2,580,852 shares of the company traded hands, compared to its average volume of 2,164,900. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. The company has a market cap of $3.64 billion, a PE ratio of -8.85, a PEG ratio of 1.83 and a beta of 0.96. The stock's 50 day moving average price is $18.99 and its 200-day moving average price is $21.83. DENTSPLY SIRONA Inc. has a 52 week low of $17.21 and a 52 week high of $34.91.
DENTSPLY SIRONA Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, January 10th. Shareholders of record on Friday, December 27th were given a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 3.49%. The ex-dividend date of this dividend was Friday, December 27th. DENTSPLY SIRONA's dividend payout ratio (DPR) is presently -30.92%.
Analyst Ratings Changes
Several equities research analysts have recently issued reports on the company. Evercore ISI reaffirmed an "in-line" rating and issued a $20.00 price objective on shares of DENTSPLY SIRONA in a research note on Tuesday, January 7th. UBS Group lowered their price target on DENTSPLY SIRONA from $35.00 to $27.00 and set a "buy" rating for the company in a research report on Tuesday, December 3rd. Barrington Research cut their price objective on shares of DENTSPLY SIRONA from $36.00 to $24.00 and set an "outperform" rating on the stock in a research report on Friday, November 8th. Robert W. Baird reduced their target price on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a "neutral" rating on the stock in a research note on Friday, November 8th. Finally, StockNews.com raised shares of DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a research note on Friday, February 7th. Ten analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus target price of $25.85.
Read Our Latest Report on XRAY
About DENTSPLY SIRONA
(
Free Report)
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Further Reading
Before you consider DENTSPLY SIRONA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.
While DENTSPLY SIRONA currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
